GSK

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 12 Mar 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,000,000€ - 1,249,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

4.3 Fte (12)

Lobbyists with EP accreditation

4

High-level Commission meetings

12

Lobbying Costs over the years

  • Info

    GSK   (GSK)

    EU Transparency Register

    7990322925-77 First registered on 06 Jan 2009

    Goals / Remit

    GSK is a global biopharmaceutical company with the purpose to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding people can thrive. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology. Our scale and strong R&D and manufacturing footprint in the EU give us a unique opportunity to make a positive impact on the lives of people in the region.

    Main EU files targeted

    Revision of EU Pharmaceutical legislation, Digital Health (European Health Data Space), Vaccination Policy, R&D policy / IHI, Antimicrobial resistance, EU Beating Cancer Plan, HERA and Biopreparedness, EU Trade, Environment and Sustainability policy, Global Health.

    Address

    Head Office
    Great West Road, 980
    Brentford, Middlesex TW8 9GS
    UNITED KINGDOM
    EU Office
    Avenue des Arts 44 / Kunstlaan 44
    Brussels 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    12

    Employment timeLobbyists
    75%3
    50%1
    25%5
    10%3

    Lobbyists (Full time equivalent)

    4.3

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    4 accreditations were / are live (in bold) for the selected state of 19 May 2024

    Name Start date End Date
    Sofia BENITO KWIECINSKI 20 Feb 2024 19 Feb 2025
    Bonifac Abel MAKKAI 20 Mar 2024 02 Oct 2024
    Alberto GIUMMARRA 12 Mar 2024 11 Mar 2025
    Gisela PAYERAS BAILLY 20 Mar 2024 02 Oct 2024
    Alberto GIUMMARRA 18 Mar 2023 12 Mar 2024
    Ms Renatte Georgescu 17 Mar 2023 16 Mar 2024
    Sofia BENITO KWIECINSKI 22 Feb 2023 20 Feb 2024
    Ms Chloe CROSS 02 Aug 2022 02 Aug 2023
    Gisela PAYERAS BAILLY 09 Apr 2022 08 Apr 2023
    Alberto GIUMMARRA 01 Apr 2022 18 Mar 2023
    Ms Renatte Georgescu 01 Apr 2022 17 Mar 2023
    Ms Chloe CROSS 15 Apr 2021 15 Apr 2022
    Gisela PAYERAS BAILLY 15 Apr 2021 09 Apr 2022
    Alberto GIUMMARRA 07 Apr 2021 01 Apr 2022
    Ms Renatte Georgescu 07 Apr 2021 01 Apr 2022
    Mihaela ALIONTE 22 Feb 2020 20 Feb 2021
    Alberto GIUMMARRA 22 Feb 2020 20 Feb 2021
    Ms Renatte Georgescu 08 Feb 2020 06 Feb 2021
    Ms Katja Murray 25 Jan 2020 01 Feb 2021
    Valentina Laurenzia Ancona 25 Jan 2020 01 Feb 2021
    Gisela PAYERAS BAILLY 08 Nov 2019 07 Nov 2020
    Ms Georgia Catherine JANE CASSARINO 17 Oct 2019 17 Oct 2020
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 05 Sep 2019 05 Sep 2020
    Christian BARACAT 05 Sep 2019 18 Oct 2019
    Mr Paulus Lambertus Antonius van Hoof 17 Aug 2019 15 Aug 2020
    Ms Renatte Georgescu 02 Feb 2019 08 Feb 2020
    Gisela PAYERAS BAILLY 31 Oct 2018 31 Oct 2019
    Ms Georgia Catherine JANE CASSARINO 26 Oct 2018 17 Oct 2019
    Christian BARACAT 05 Sep 2018 05 Sep 2019
    Mr Paulus Lambertus Antonius van Hoof 07 Aug 2018 07 Aug 2019
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 19 Jun 2018 19 Jun 2019
    Gisela PAYERAS BAILLY 27 Oct 2017 26 Oct 2018
    Ms Georgia Catherine JANE CASSARINO 27 Oct 2017 25 Oct 2018
    Christian BARACAT 31 Aug 2017 17 Aug 2018
    Mr Paulus Lambertus Antonius van Hoof 31 Aug 2017 07 Aug 2018
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 10 Oct 2016 07 Oct 2017
    Gisela PAYERAS BAILLY 05 Sep 2016 31 Aug 2017
    Christian BARACAT 22 Aug 2016 02 Aug 2017
    Mr Paulus Lambertus Antonius van Hoof 22 Aug 2016 02 Aug 2017
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 26 Sep 2015 25 Sep 2016
    Ms Karin Jeanette Drielsma 22 Sep 2015 31 Jan 2016
    Christian BARACAT 29 Aug 2015 23 Aug 2016
    Gisela PAYERAS BAILLY 29 Aug 2015 28 Aug 2016
    Mr Paulus Lambertus Antonius van Hoof 31 Jul 2015 29 Jul 2016
    Ms Karin Jeanette Drielsma 06 Aug 2014 04 Aug 2015
    Ms Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 28 Aug 2015
    Gisela PAYERAS BAILLY 26 Aug 2014 19 Aug 2015
    Mr Nicholas Collinge Crosby 08 Oct 2014 03 Jun 2015
    Ms Diana Mereu 04 Oct 2014 03 Jun 2015
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 30 Sep 2014 26 Sep 2015
    Mrs Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 27 Jan 2015
    Christian BARACAT 26 Aug 2014 19 Aug 2015
    Gisela PAYERAS BAILLY 26 Aug 2014 27 Jan 2015
    Mrs Karin Jeanette Drielsma 06 Aug 2014 27 Jan 2015
    Mr Paulus Lambertus Antonius van Hoof 02 Aug 2014 31 Jul 2015
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 28 Sep 2013 27 Sep 2014
    Mrs Elisaveta Voynova 28 Sep 2013 27 Sep 2014
    Mr Paulus Lambertus Antonius van Hoof 25 Jul 2013 24 Jul 2014
    Gisela PAYERAS BAILLY 25 Jul 2013 24 Jul 2014
    Mr Christopher Black 23 Jul 2013 20 Jul 2014
    Mr Johan Christoffer Thor 23 Jul 2013 20 Jul 2014
    Mrs Karin Jeanette Drielsma 23 Jul 2013 20 Jul 2014
    Mrs Sophie Renee Jeanne Marie Philippine Crousse 23 Jul 2013 20 Jul 2014
    Mr Philippe GHYSSELS 17 Jan 2012 08 Feb 2013

    Complementary Information

    Our Brussels office has five representatives, three of which focus on EU affairs and two whose work focuses on trade associations and initiatives within the EU Member States. The remaining colleagues are involved in very limited EU activities and spend less than 25% of their time on in-scope activities; as per the guidance under the Inter-Institutional Agreement of 2021 we have included these individuals. GSK also follows the guidelines provided by EFPIA regarding this registration.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    American Chamber of Commerce to the European Union (AmChamEU)
    European Federation of Pharmaceutical Industries and Associations (EFPIA)
    Vaccines Europe (VE)
    International Pharmaceutical Aerosol Consortium (IPAC)
    Digital Europe
    MedTech Europe
    European Policy Centre (EPC)
    Friends of Europe
    Ambrosetti
    European Roundtable for Industry (ERT)
    RPP Group
    British Chamber of Commerce EU & Belgium

    Member organisations

    N/A

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    1,000,000€ - 1,249,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    rpp group 10,000€ - 24,999€

    Intermediaries for current year

    Name
    rpp group

    Closed year Costs

    1,000,000€ - 1,249,999€

    Other financial info

    GSK is following the Transparency Register Code of Conduct and Implementing Guidelines. The organisation is also following the EFPIA Codes.
    The amount declared in answer (c) includes: relevant percentage of trade associations' work, consultants as declared, percentage of employees and their salaries whose activities are considered in-scope.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Mainly via participation in events organised by think tanks and trade associations.

    Other activities

    None declared

  • Meetings

    Meetings

    12 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 28 Apr 2021 Location Brussels
      Subject EU vaccine production and pandemic preparedness
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 11 Feb 2021 Location webex
      Subject vaccines
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 31 May 2018 Location Brussels
      Subject Brexit preparedness
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
    • Date 23 Mar 2018 Location Brussels
      Subject IP regime generic manufacturers in the pharmaceutical industry
      Cabinet Cabinet of Commissioner Pierre Moscovici
      Portfolio Economic and Financial Affairs, Taxation and Customs
      Attending
      • Leila Fernandez-Stembridge (Cabinet member)
    • Date 01 Dec 2017 Location Brussels
      Subject FTA implementation & transparency / trade relations with China, Turkey, Russia / importance of including vaccines in trade negotiations
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Maria Asenius (Cabinet member)
      • Nele Eichhorn (Cabinet member)
    • Date 09 Nov 2017 Location Brussels
      Subject Innovation in the pharmaceutical sector, SPC, health technology assessments
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Marika Lautso-Mousnier (Cabinet member)
    • Date 26 Jun 2017 Location Brussels
      Subject Antimicrobial resistance (AMR)
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Carlos Moedas (Commissioner)
    • Date 30 Sep 2015 Location Brussels
      Subject Vaccination
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Paula Duarte Gaspar (Cabinet member)
    • Date 24 Sep 2015 Location Brussels
      Subject Challenges of the pharma industry
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Carlos Moedas (Commissioner)
    • Date 18 May 2015 Location Brussels
      Subject Access to medicines in Africa
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Cécile Billaux (Cabinet member)
    • Date 16 Jan 2015 Location PRAGUE, CZECH REPUBLIC
      Subject Round Table on Gender Diversity
      Cabinet Cabinet of Commissioner Věra Jourová
      Portfolio Justice, Consumers and Gender Equality
      Attending
      • Věra Jourová (Commissioner)
      Other Lobbyists
    • Date 05 Dec 2014 Location Brussels
      Subject Life sciences contribution to growth and jobs
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Aura Salla (Cabinet member)
      • Heidi Jern (Cabinet member)
Download this datacard